The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 31, 2017

Filed:

Mar. 14, 2014
Applicant:

Bayer Healthcare Llc, Tarrytown, NY (US);

Inventors:

John Murphy, Cambridge, MA (US);

Zhuozhi Wang, Millbrae, CA (US);

Ruth Winter, Oakland, CA (US);

Assignee:

BAYER HEALTHCARE LLC, Whippany, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/38 (2006.01);
U.S. Cl.
CPC ...
C07K 16/38 (2013.01); C07K 2317/14 (2013.01); C07K 2317/30 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01);
Abstract

Antibodies are disclosed that bind to and inhibit the anti-coagulant function of TFPI and have a lower affinity for TFPI at pH 6.0 than at pH 7.4. The lower affinity at pH 6 improves circulating half-life (T½) due to reduced target mediated clearance, a process by which an antibody/antigen complex is endocytosed and trafficked to the lysosome where both components are degraded. The lower affinity at pH 6.0 results in disruption of the complex prior to lysosome targeting and allows for re-circulation of the antibody. Specific modifications to antibody binding by histidine residue substitution are disclosed along with methods of use.


Find Patent Forward Citations

Loading…